Pharma-Bio Serv (OTCMKTS:PBSV) Issues Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) posted its quarterly earnings data on Thursday. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02, Yahoo Finance reports. The firm had revenue of $4.58 million for the quarter, compared to analysts’ expectations of $5.40 million. Pharma-Bio Serv had a return on equity of 7.91% and a net margin of 7.09%.

Pharma-Bio Serv Stock Performance

Shares of OTCMKTS PBSV traded down $0.06 during mid-day trading on Friday, reaching $0.92. The company had a trading volume of 2,904 shares, compared to its average volume of 2,054. The firm has a market cap of $21.14 million, a price-to-earnings ratio of 16.34 and a beta of 0.41. The business’s 50-day simple moving average is $0.96 and its 200 day simple moving average is $0.96. Pharma-Bio Serv has a one year low of $0.68 and a one year high of $1.20.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies.

See Also

Earnings History for Pharma-Bio Serv (OTCMKTS:PBSV)

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with's FREE daily email newsletter.